Inventor

CHAKRAVARTY PRASUN K

US50 patents

⚠️ This page may combine multiple inventors who share the name “CHAKRAVARTY PRASUN K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHAKRAVARTY PRASUN K

MERCK & CO INC

Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists

Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives

Angiotensin ii antagonists

Phenoxyphenylacetic acid derivatives

Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists

Substituted pyrazolopyrimidines as angiotensin II antagonists

Quinoline angiotensin ii antagonists incorporating a substituted benzyl element

Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists

Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists

Oxo-purines as angiotensin II antagonists

Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists

Substituted pyrimidinones as angiotensin ii antagonists

Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone

Biphenyl compounds useful or endothelin antagonists

3-substituted piperidines promote release of growth hormone

Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives

Disubstituted 6-aminoquinazolinones

Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists

Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists

Substituted quinazolinones as angiotensin II antagonists

Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists

Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders

Method for inhibiting activation of the human A3 adenosine receptor to treat asthma

Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists

Angiotensin ii antagonists incorporating a substituted benzyl element

Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle

Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists

Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers

Substituted 1,2,4-triazolin-3-one compounds bearing acidic functional groups as balanced angiotensin II antagonists

Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists

Substituted imidazopyridazines as angiotensin II antagonists

Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists

Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists

Imidazole angiotensin ii antagonists incorporating acidic functional groups

Renin inhibitors containing phenylalanyl-histidine replacements

Phenoxyphenylacetic acid derivatives

Substituted phthalazinones as neurotensin antagonists

Substituted biphenylmethylimidazopyridines

Quinazolinones substituted with phenoxyphenylacetic acid derivatives

Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis

Renin inhibitors containing phenylalanyl-histidine replacements

Substituted triazoles as angiotensin II antagonists

C1 to C4 side chain modified nodulisporic acid analogs

Biaryl substituted pyrazoles as sodium channel blockers

Biaryl substituted triazoles as sodium channel blockers

Substituted triazoles as sodium channel blockers

Process for preparing ACHPA

Biaryl substituted triazoles as sodium channel blockers

Renin inhibitors containing phenylalanyl-histidine replacements

CHAKRAVARTY PRASUN K

Substituted aryl sulfone derivatives as calcium channel blockers